Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB),…
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB),…
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH)…
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / Viridium Pacific Group Ltd. (“Viridium” or…
Companies to Combine Cutting-Edge Delivery Technologies, Coupled with Advanced Computational Capabilities and Robotics for Development…
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options LIVINGSTON,…
Efficacy data from the REIMAGINE Phase IIa basket trial’s Borderline Personality Disorder (BPD) cohort Vafidemstat…
– Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3…
VANCOUVER, BC / ACCESSWIRE / April 5, 2019 / EVITRADE Health Systems Corp. (CSE: EVA,…
Parnell Delivers 39% Revenue Growth and a $6.5 Million Improvement in EBITDA in 2018 Compared…
LAWRENCE, MA / ACCESSWIRE / April 4, 2019 / Healthcare spending in the United States…